Imricor Medical Systems financials at a glance

+ Portfolio

The revenue of Imricor Medical Systems is reported as 0.00082 billion Dollars in the fiscal year 2023. The earnings were -0.12 Dollars per share in 2023, which was 0 higher than 2022. And about -0.01725 billion Dollars are reported as free cash flow in the financials of Imricor Medical Systems 2023. No dividends were paid to the shareholders of the Imricor Medical Systems stock ASX:IMR in the financial year 2023.

$0.82M

Revenue

$-0.12

Earnings Per Share

-,181.27%

Gross Margin %

$-12.80M

Free Cash Flow

Revenue

0.82

Earnings Per Share

-0.12

Gross Margin %

-,181.27

Free Cash Flow

-12.80

Financials

Year	Year	TTM	2023	2022	2021	2020
Rev.	Revenue	N/A	$0.82M	$0.82M	$0.70M	$0.70M
GM %	Gross Margin %	-,296.01%	-,181.27%	-,187.10%	-,272.30%	-56.64%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.11	$-0.12	$-0.12	$-0.15	$-0.11
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	168.92M	151.35M	143.23M	125.55M
OCF	Operating Cash Flow	N/A	$-16.51M	$-16.51M	$-17.49M	$-12.23M
FCF	Free Cash Flow	N/A	$-12.80M	$-16.75M	$-18.11M	$-12.97M
FCFS	Free Cash Flow Per Share	$-0.10	$-0.08	$-0.11	$-0.14	$-0.12

Imricor Medical Systems financials at a glance

Financials

Discover